Selected research
Market Structure
Global Anti-Smoking Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-Smoking Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-Smoking Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Smoking Products include Takeda pharmaceutical, Novartis International, Pfizer, GSK, VMR products, VaporCorp, Revolymer plc, NJOY and McNeil AB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Anti-Smoking Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Smoking Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Smoking Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anti-Smoking Products market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Smoking Products Segment by Company
Takeda pharmaceutical
Novartis International
Pfizer
GSK
VMR products
VaporCorp
Revolymer plc
NJOY
McNeil AB
Lorillard
Imperial Tobacco
Elder Pharma
Cipla
Anti-Smoking Products Segment by Type
Drug therapy
Nicotine Replacement Therapy
E-cigarettes
Anti-Smoking Products Segment by Application
Smokers aged 65 years or older
Smokers aged 45–64
Smokers aged 25–44
Smokers aged 18–24
Anti-Smoking Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Smoking Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Smoking Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Smoking Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-Smoking Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Smoking Products industry.
Chapter 3: Detailed analysis of Anti-Smoking Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Smoking Productsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drug therapy
- Nicotine Replacement Therapy
- E-cigarettes
Applications
- Smokers aged 65 years or older
- Smokers aged 45–64
- Smokers aged 25–44
- Smokers aged 18–24
Companies covered
- Takeda pharmaceutical
- Novartis International
- Pfizer
- GSK
- VMR products
- VaporCorp
- Revolymer plc
- NJOY
- McNeil AB
- Lorillard
- Imperial Tobacco
- Elder Pharma
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Anti-Smoking Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Drug therapy
- 1.2.3 Nicotine Replacement Therapy
- 1.2.4 E-cigarettes
- 1.3 Market Analysis by Application
- 1.3.1 Global Anti-Smoking Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Smokers aged 65 years or older
- 1.3.3 Smokers aged 45–64
- 1.3.4 Smokers aged 25–44
- 1.3.5 Smokers aged 18–24
- 1.4 Global Market Growth Prospects
- 1.5 Global Anti-Smoking Products Growth Trends by Region
- 1.5.1 Global Anti-Smoking Products Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Anti-Smoking Products Market Size by Region (2021-2026)
- 1.5.3 Anti-Smoking Products Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Anti-Smoking Products Market Dynamics
- 2.1 Anti-Smoking Products Industry Trends
- 2.2 Anti-Smoking Products Industry Drivers
- 2.3 Anti-Smoking Products Industry Opportunities and Challenges
- 2.4 Anti-Smoking Products Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Anti-Smoking Products Revenue by Company (2021-2026)
- 3.2 Global Anti-Smoking Products Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Anti-Smoking Products Key Company Head office and Area Served
- 3.4 Global Anti-Smoking Products Company, Product Type & Application
- 3.5 Global Anti-Smoking Products Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Anti-Smoking Products Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Anti-Smoking Products Players Market Share by Revenue in 2025
- 3.6.3 2025 Anti-Smoking Products Tier 1, Tier 2, and Tier 3
4 Anti-Smoking Products Market by Type
- 4.1 Global Anti-Smoking Products Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Anti-Smoking Products Market Size by Type (2021-2032)
- 4.3 Global Anti-Smoking Products Market Size Share by Type (2021-2032)
5 Anti-Smoking Products Market by Application
- 5.1 Global Anti-Smoking Products Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Anti-Smoking Products Market Size by Application (2021-2032)
- 5.3 Global Anti-Smoking Products Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Takeda pharmaceutical
- 6.1.1 Takeda pharmaceutical Company Information
- 6.1.2 Takeda pharmaceutical Business Overview
- 6.1.3 Takeda pharmaceutical Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Takeda pharmaceutical Anti-Smoking Products Product Portfolio
- 6.1.5 Takeda pharmaceutical Recent Developments
- 6.2 Novartis International
- 6.2.1 Novartis International Company Information
- 6.2.2 Novartis International Business Overview
- 6.2.3 Novartis International Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Novartis International Anti-Smoking Products Product Portfolio
- 6.2.5 Novartis International Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Pfizer Anti-Smoking Products Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 GSK
- 6.4.1 GSK Company Information
- 6.4.2 GSK Business Overview
- 6.4.3 GSK Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 GSK Anti-Smoking Products Product Portfolio
- 6.4.5 GSK Recent Developments
- 6.5 VMR products
- 6.5.1 VMR products Company Information
- 6.5.2 VMR products Business Overview
- 6.5.3 VMR products Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 VMR products Anti-Smoking Products Product Portfolio
- 6.5.5 VMR products Recent Developments
- 6.6 VaporCorp
- 6.6.1 VaporCorp Company Information
- 6.6.2 VaporCorp Business Overview
- 6.6.3 VaporCorp Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 VaporCorp Anti-Smoking Products Product Portfolio
- 6.6.5 VaporCorp Recent Developments
- 6.7 Revolymer plc
- 6.7.1 Revolymer plc Company Information
- 6.7.2 Revolymer plc Business Overview
- 6.7.3 Revolymer plc Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Revolymer plc Anti-Smoking Products Product Portfolio
- 6.7.5 Revolymer plc Recent Developments
- 6.8 NJOY
- 6.8.1 NJOY Company Information
- 6.8.2 NJOY Business Overview
- 6.8.3 NJOY Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 NJOY Anti-Smoking Products Product Portfolio
- 6.8.5 NJOY Recent Developments
- 6.9 McNeil AB
- 6.9.1 McNeil AB Company Information
- 6.9.2 McNeil AB Business Overview
- 6.9.3 McNeil AB Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 McNeil AB Anti-Smoking Products Product Portfolio
- 6.9.5 McNeil AB Recent Developments
- 6.10 Lorillard
- 6.10.1 Lorillard Company Information
- 6.10.2 Lorillard Business Overview
- 6.10.3 Lorillard Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Lorillard Anti-Smoking Products Product Portfolio
- 6.10.5 Lorillard Recent Developments
- 6.11 Imperial Tobacco
- 6.11.1 Imperial Tobacco Company Information
- 6.11.2 Imperial Tobacco Business Overview
- 6.11.3 Imperial Tobacco Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Imperial Tobacco Anti-Smoking Products Product Portfolio
- 6.11.5 Imperial Tobacco Recent Developments
- 6.12 Elder Pharma
- 6.12.1 Elder Pharma Company Information
- 6.12.2 Elder Pharma Business Overview
- 6.12.3 Elder Pharma Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Elder Pharma Anti-Smoking Products Product Portfolio
- 6.12.5 Elder Pharma Recent Developments
- 6.13 Cipla
- 6.13.1 Cipla Company Information
- 6.13.2 Cipla Business Overview
- 6.13.3 Cipla Anti-Smoking Products Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cipla Anti-Smoking Products Product Portfolio
- 6.13.5 Cipla Recent Developments
7 North America
- 7.1 North America Anti-Smoking Products Market Size (2021-2032)
- 7.2 North America Anti-Smoking Products Market Size by Type
- 7.2.1 North America Anti-Smoking Products Market Size by Type (2021-2026)
- 7.2.2 North America Anti-Smoking Products Market Size by Type (2027-2032)
- 7.2.3 North America Anti-Smoking Products Market Share by Type (2021-2032)
- 7.3 North America Anti-Smoking Products Market Size by Application
- 7.3.1 North America Anti-Smoking Products Market Size by Application (2021-2026)
- 7.3.2 North America Anti-Smoking Products Market Size by Application (2027-2032)
- 7.3.3 North America Anti-Smoking Products Market Share by Application (2021-2032)
- 7.4 North America Anti-Smoking Products Market Size by Country
- 7.4.1 North America Anti-Smoking Products Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Anti-Smoking Products Market Size by Country (2021-2026)
- 7.4.3 North America Anti-Smoking Products Market Size by Country (2027-2032)
- 7.4.4 North America Anti-Smoking Products Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Anti-Smoking Products Market Size (2021-2032)
- 8.2 Europe Anti-Smoking Products Market Size by Type
- 8.2.1 Europe Anti-Smoking Products Market Size by Type (2021-2026)
- 8.2.2 Europe Anti-Smoking Products Market Size by Type (2027-2032)
- 8.2.3 Europe Anti-Smoking Products Market Share by Type (2021-2032)
- 8.3 Europe Anti-Smoking Products Market Size by Application
- 8.3.1 Europe Anti-Smoking Products Market Size by Application (2021-2026)
- 8.3.2 Europe Anti-Smoking Products Market Size by Application (2027-2032)
- 8.3.3 Europe Anti-Smoking Products Market Share by Application (2021-2032)
- 8.4 Europe Anti-Smoking Products Market Size by Country
- 8.4.1 Europe Anti-Smoking Products Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Anti-Smoking Products Market Size by Country (2021-2026)
- 8.4.3 Europe Anti-Smoking Products Market Size by Country (2027-2032)
- 8.4.4 Europe Anti-Smoking Products Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Anti-Smoking Products Market Size (2021-2032)
- 9.2 China Anti-Smoking Products Market Size by Type
- 9.2.1 China Anti-Smoking Products Market Size by Type (2021-2026)
- 9.2.2 China Anti-Smoking Products Market Size by Type (2027-2032)
- 9.2.3 China Anti-Smoking Products Market Share by Type (2021-2032)
- 9.3 China Anti-Smoking Products Market Size by Application
- 9.3.1 China Anti-Smoking Products Market Size by Application (2021-2026)
- 9.3.2 China Anti-Smoking Products Market Size by Application (2027-2032)
- 9.3.3 China Anti-Smoking Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Anti-Smoking Products Market Size (2021-2032)
- 10.2 Asia Anti-Smoking Products Market Size by Type
- 10.2.1 Asia Anti-Smoking Products Market Size by Type (2021-2026)
- 10.2.2 Asia Anti-Smoking Products Market Size by Type (2027-2032)
- 10.2.3 Asia Anti-Smoking Products Market Share by Type (2021-2032)
- 10.3 Asia Anti-Smoking Products Market Size by Application
- 10.3.1 Asia Anti-Smoking Products Market Size by Application (2021-2026)
- 10.3.2 Asia Anti-Smoking Products Market Size by Application (2027-2032)
- 10.3.3 Asia Anti-Smoking Products Market Share by Application (2021-2032)
- 10.4 Asia Anti-Smoking Products Market Size by Country
- 10.4.1 Asia Anti-Smoking Products Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Anti-Smoking Products Market Size by Country (2021-2026)
- 10.4.3 Asia Anti-Smoking Products Market Size by Country (2027-2032)
- 10.4.4 Asia Anti-Smoking Products Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Anti-Smoking Products Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Anti-Smoking Products Market Size by Type
- 11.2.1 South America, Middle East & Africa Anti-Smoking Products Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Anti-Smoking Products Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Anti-Smoking Products Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Anti-Smoking Products Market Size by Application
- 11.3.1 South America, Middle East & Africa Anti-Smoking Products Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Anti-Smoking Products Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Anti-Smoking Products Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Anti-Smoking Products Market Size by Country
- 11.4.1 South America, Middle East & Africa Anti-Smoking Products Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Anti-Smoking Products Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Anti-Smoking Products Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Anti-Smoking Products Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst